Clinical Trial Detail

NCT ID NCT03000179
Title Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

ampulla of Vater carcinoma

duodenum cancer

small intestine adenocarcinoma

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.